AGPU earnings analysis
What we found in AGPU's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted 10-Q text does not include reported revenue, margins, EPS, balance-sheet figures, or cash-flow data, preventing assessment of quarterly financial trends. Management states that disclosure controls were effective as of June 30, 2026 and describes enhanced controls supporting the transition into compute services and digital-asset operations. The principal update is the expansion into capital-intensive owned GPU infrastructure, with material execution, financing, power, supplier, customer-concentration, and technology-obsolescence risks.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Disclosure controls deemed effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026.
- Revenue and digital-asset controls enhanced
- The company implemented new revenue-recognition processes and controls during the quarter ended June 30, 2026, including controls for compute services and digital-asset operations.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Power constraints could delay expansion
- The largest deployment to date requires 4.8 megawatts of committed power capacity, exposing the company to power availability, cost, permitting, and regulatory risks.
- GPU deployment execution risk
- The largest contract contemplates a targeted deployment start in the third quarter of 2026; hardware, facility, or integration delays could lead to penalties, delayed revenue, customer disputes, or termination rights.
- Revenue concentration and counterparty risk
- Projected compute revenue is expected to be concentrated among a limited number of customers, including an approximately $260 million enterprise engagement, increasing counterparty and customer-concentration risk.
What they said about what is next.
No quantitative revenue or EPS guidance is provided in the extracted 10-Q text. The filing references a targeted deployment start in the third quarter of 2026, but does not provide numeric financial guidance.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 15, 2026
- Axe Compute's Q1 2026 results indicate a sharp decline in revenue and a significant loss in earnings per share compared to the previous periods. Revenue dropped to $35,311, while the reported EPS was -$122.75,…
- 10-K · March 31, 2026
- Axe Compute (AGPU) has pivoted from oncology services to a GPU compute + digital asset treasury strategy (Aethir/ATH), financed by PIPE transactions totaling approximately $343.5 million. The company reported Q4 revenue…
- 10-Q · August 13, 2025
- Predictive Oncology reported Q2 2025 revenue of $2,682 (down sharply from $67,255 in Q2 2024) and a net loss of $2,070,462 (improved vs $3,181,261 in Q2 2024). The company continues to burn cash (net cash used in…
- 10-Q · May 14, 2025
- Predictive Oncology reported Q1 2025 revenue of $110,310 (up from $4,858 in Q1 2024) and generated a gross profit of $65,192 versus a gross loss of $(17,575) a year earlier. The company narrowed its net loss to…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing AGPU makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever